Hualiang Huang

Title: Hualiang Huang: Innovator in Cancer Treatment

Introduction

Hualiang Huang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biotechnology, particularly in the development of innovative treatments for cancer. His work focuses on creating targeted therapies that can improve patient outcomes.

Latest Patents

Hualiang Huang holds a patent for an "Anti-human ovarian cancer-anti CD3 bispecific antibody." This invention provides a bispecific antibody designed to target ovarian cancer. The antibody consists of two polypeptide domains connected by a polypeptide linker. One domain is an anti-ovarian cancer antibody, while the other is an anti-CD3 antibody. The invention also includes DNA sequences encoding the antibody, an expression vector containing the DNA sequence, and a host cell containing the expression vector. Hualiang Huang has 1 patent to his name.

Career Highlights

Throughout his career, Hualiang Huang has worked with various companies, including Beijing Abt Genetic Engineering Technology Co. Ltd. and Dongguan Haofa Biotechnology Development Co. Ltd. His experience in these organizations has allowed him to advance his research and contribute to the development of innovative biotechnological solutions.

Collaborations

Hualiang Huang has collaborated with notable professionals in his field, including Xin Jiang and Min Fang. These partnerships have facilitated the exchange of ideas and expertise, further enhancing his contributions to cancer research.

Conclusion

Hualiang Huang is a dedicated inventor whose work in cancer treatment showcases the potential of biotechnology to transform healthcare. His innovative approaches and collaborations continue to pave the way for advancements in the fight against cancer.